Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study-Reference-Cited by-同舟云学术

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A gynecologic oncology group study

Published:2011-11 Issue:2 Volume:123 Page:182-186
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Dizon Don S.,Sill Michael W.,Gould Natalie,Rubin Stephen C.,Yamada S. Diane,DeBernardo Robert L.,Mannel Robert S.,Eisenhauer Eric L.,Duska Linda R.,Fracasso Paula M.

Funder

National Cancer Institute

Gynecologic Oncology Group Statistical and Data Center

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference18 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. Intraperitoneal chemotherapy in ovarian cancer: an update;Runowicz;Cancer J,2008

3. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer;Alberts;N Engl J Med,1996

4. Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

5. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N Engl J Med,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to F. Tomao et al and E.A. De Jaeghere et al;Journal of Clinical Oncology;2019-11-20

2. Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Old and Novel Questions;Journal of Clinical Oncology;2019-11-20

3. Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study;Journal of Clinical Oncology;2019-06-01

4. Tumeurs épithéliales malignes de l’ovaire : place de la chimiothérapie intrapéritonéale et de la chimiothérapie hyperthermique intrapéritonéale (CHIP). Article rédigé sur la base de la recommandation nationale de bonnes pratiques cliniques en cancérologie intitulée « Conduites à tenir initiales devant des patientes atteintes d’un cancer épithélial de l’ovaire » élaborée par FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY sous l’égide du CNGOF et labellisée par l’INCa;Gynécologie Obstétrique Fertilité & Sénologie ;2019-02

5. Current First-line Therapy for Ovarian Cancer: A Comprehensive Review;Obstetrical & Gynecological Survey;2018-11